1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grants2027 Grant Application is sponsored by The Genesis Foundation for Children. The Genesis Foundation for Children offers grants to fund clinical, educational, and therapy programs for children and young adults in New England with genetic disorders, rare diseases, and intellectual and physical disabilities.
Get alerted about grants like this
Get emailed when new opportunities from “The Genesis Foundation for Children” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Programs for children and young adults in New England with genetic disorders, rare diseases, and intellectual and physical disabilities. Organizations must be located in the six New England states: Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire, and Vermont. Confirm the full requirements in the official notice before applying.
Applications for 2027 Grant Application are due September 1, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
2027 Grant Application is funded by The Genesis Foundation for Children. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Massachusetts, New Hampshire, Rhode Island, Connecticut, Vermont, and Maine. Check the official notice for exact location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.
The White House committed more than $5 billion across 15+ federal agencies to the Genesis Mission, and DOE selected 278 first-cohort projects out of roughly 5,000 applications — the largest response to any DOE funding call ever. Phase I grants run $500,000 to $750,000 over 9 months; Phase II awards reach $6 million to $15 million over 3 years, with one $60 million flagship. Here is the full architecture, the eligibility math, and how to position for the next window.
Read articleThe Trump administration committed $5B and 278 projects across 15+ agencies to the Genesis Mission. Here's the structure — and how to position for the next wave.
Read articleNSF just committed $380 million to build a national network of AI-programmable, remotely operated laboratories — the Programmable Cloud Laboratories Test Bed (NSF 25-541), the agency's flagship contribution to the Genesis Mission. Twenty nodes, four years, self-driving experiments in chemistry, biology and materials. Here is what it funds, who is eligible, why the 'existing facilities only' rule matters, and how researchers and companies should position for what comes next.
Read article